InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,722.26
(
-0.19%
)
US TECH 100
19,710.80
(
1.43%
)
Dow Jones
41,914.75
(
-0.70%
)
Brent Oil
71.45
(
-2.38%
)
Bitcoin
63,781.39
(
1.03%
)
Post# of 253225
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

RNsidersbuying

Send PM Follow Ignore
Followers 46
Posts 4548
Boards Moderated 0
Alias Born 07/26/2010

RNsidersbuying

Re: maverick_1 post# 194316

Monday, 10/05/2015 11:09:04 AM

Monday, October 05, 2015 11:09:04 AM

Post# of 253225
IMUC .41 - receives $19.9M grant from California Institute for Regenerative Medicine (CIRM)...to support the ICT-107 phase 3 registration trial in patients with newly diagnosed glioblastoma:

http://www.marketwatch.com/story/immunocellular-therapeutics-awarded-199-million-grant-from-california-institute-for-regenerative-medicine-cirm-to-fund-ict-107-phase-3-registration-program-in-glioblastoma-2015-09-24?siteid=bigcharts&dist=bigcharts

With .30 cash on the books now, I figure this adds another .22 in cash therefore it's now trading below cash with a phase3 in progress and backing of a governmental agency.

Bought .41's with bids below.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up